Literature DB >> 16008684

Risk factors and characteristics associated with severe and difficult to treat asthma phenotype: an analysis of the ENFUMOSA group of patients based on the ECRHS questionnaire.

M Gaga1, N Papageorgiou, G Yiourgioti, P Karydi, A Liapikou, H Bitsakou, E Zervas, N G Koulouris, S T Holgate.   

Abstract

BACKGROUND: Severe and difficult to treat asthma impairs health status and accounts for about half of asthma expenditure. In 1994, a European Network For Understanding Mechanisms of Severe Asthma (ENFUMOSA) was formed. A large group of patients from nine European countries has been selected.
OBJECTIVE: To examine the risk factors and symptoms associated with a phenotype of severe/difficult to treat asthma.
METHODS: The present report presents data assessed through the use of the European Community Respiratory Health Survey (ECRHS) Questionnaire in 148 mild-moderate controlled and 155 severe asthmatics from the ENFUMOSA group.
RESULTS: There is a negative association of severe asthma with reported allergy and with a family history of allergy (Odds ratio (OR)=0.45). Sharing a bedroom before the age of five is associated with a higher risk of severe asthma (OR=1.5) while childhood infections, play school attendance and exposure to allergens or animals are not. A larger proportion of severe asthma patients report symptoms at work (OR=2.7) or have to change jobs (OR=4.3) and fewer severe than mild patients are currently employed (OR=0.39). Smoking and exposure to smoke is similar in mild and severe asthma. Dietary habits do not differ between the groups, but severe asthmatics report eating less savoury snacks and there is a trend for lower intake of sweets.
CONCLUSIONS: Analysis of the ECRHS questionnaire in the ENFUMOSA study shows that severe asthma patients experience more symptoms and their health status is impaired by their inability to work and perhaps eat freely. Personal and maternal history of allergy is associated with mild but not severe asthma. Other than sharing a bedroom before the age of 5 years, no childhood exposure risk factors associated with severe asthma could be identified from this analysis.

Entities:  

Mesh:

Year:  2005        PMID: 16008684     DOI: 10.1111/j.1365-2222.2005.02281.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  12 in total

1.  Influenza vaccination among persons with work-related asthma.

Authors:  Jacek M Mazurek; Gretchen E White; Jeanne E Moorman; Eileen Storey
Journal:  Am J Prev Med       Date:  2014-06-18       Impact factor: 5.043

2.  The Saudi Initiative for Asthma - 2019 Update: Guidelines for the diagnosis and management of asthma in adults and children.

Authors:  Mohamed S Al-Moamary; Sami A Alhaider; Abdullah A Alangari; Mohammed O Al Ghobain; Mohammed O Zeitouni; Majdy M Idrees; Abdullah F Alanazi; Adel S Al-Harbi; Abdullah A Yousef; Hassan S Alorainy; Mohamed S Al-Hajjaj
Journal:  Ann Thorac Med       Date:  2019 Jan-Mar       Impact factor: 2.219

3.  Multi-symptom asthma is closely related to nasal blockage, rhinorrhea and symptoms of chronic rhinosinusitis-evidence from the West Sweden Asthma Study.

Authors:  Jan Lötvall; Linda Ekerljung; Bo Lundbäck
Journal:  Respir Res       Date:  2010-11-26

4.  Gastrin-releasing peptide blockade as a broad-spectrum anti-inflammatory therapy for asthma.

Authors:  Shutang Zhou; Erin N Potts; Frank Cuttitta; W Michael Foster; Mary E Sunday
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-20       Impact factor: 11.205

Review 5.  The irreversible component of persistent asthma.

Authors:  Rodolfo M Pascual; Stephen P Peters
Journal:  J Allergy Clin Immunol       Date:  2009-11       Impact factor: 10.793

6.  Characteristics of perimenstrual asthma and its relation to asthma severity and control: data from the Severe Asthma Research Program.

Authors:  Chitra K Rao; Charity G Moore; Eugene Bleecker; William W Busse; William Calhoun; Mario Castro; Kian Fan Chung; Serpil C Erzurum; Elliot Israel; Douglas Curran-Everett; Sally E Wenzel
Journal:  Chest       Date:  2013-04       Impact factor: 9.410

7.  Iron supplementation decreases severity of allergic inflammation in murine lung.

Authors:  Laura P Hale; Erin Potts Kant; Paula K Greer; W Michael Foster
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

8.  Difficult-to-treat asthma, is it really difficult?

Authors:  Mohamed S Al-Hajjaj
Journal:  Ann Thorac Med       Date:  2011-01       Impact factor: 2.219

9.  The Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and children.

Authors:  Mohamed S Al-Moamary; Sami A Alhaider; Mohamed S Al-Hajjaj; Mohammed O Al-Ghobain; Majdy M Idrees; Mohammed O Zeitouni; Adel S Al-Harbi; Maha M Al Dabbagh; Hussain Al-Matar; Hassan S Alorainy
Journal:  Ann Thorac Med       Date:  2012-10       Impact factor: 2.219

Review 10.  Clinical asthma phenotypes in the real world: opportunities and challenges.

Authors:  Clementine Bostantzoglou; Vicky Delimpoura; Konstantinos Samitas; Eleftherios Zervas; Frank Kanniess; Mina Gaga
Journal:  Breathe (Sheff)       Date:  2015-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.